Family history of diabetes is associated with higher risk for prediabetes: a multicentre analysis from the German Center for Diabetes Research
- First Online:
- Cite this article as:
- Wagner, R., Thorand, B., Osterhoff, M.A. et al. Diabetologia (2013) 56: 2176. doi:10.1007/s00125-013-3002-1
Prediabetes is a collective term for different subphenotypes (impaired glucose tolerance [IGT] and/or impaired fasting glucose [IFG]) with different pathophysiologies. A positive family history for type 2 diabetes (FHD) is associated with increased risk for type 2 diabetes. We assumed that it would also associate with prediabetes, but wondered whether all subphenotypes are related to a positive family history.
In a study population of 8,106 non-diabetic individuals of European origin collected from four study centres (normal glucose tolerance, NGT n = 5,482, IFG and/or IGT n = 2,624), we analysed whether having at least one first degree relative with diabetes is associated with prediabetes. The analyses were performed using the same models in each population separately. Afterwards, a meta-analysis was performed.
FHD was significantly associated with the risk for prediabetes (IFG and/or IGT, OR 1.40; 95% CI 1.27, 1.54). This association remained significant in multivariable logistic regression models including sex, age and BMI (OR 1.26; 95% CI 1.14, 1.40). When different prediabetic outcomes were considered separately, the association was found for isolated IFG (OR 1.37; 95% CI 1.20, 1.57), isolated IGT (OR 1.25; 95% CI 1.07, 1.46) as well as for the combination IFG+IGT (OR 1.64; 95% CI 1.40, 1.93). After stratification on BMI, association between FHD and prediabetes was seen only in non-obese individuals (BMI < 30 kg/m2).
We found that FHD is an important risk factor for prediabetes, especially for combined IGT and IFG. Its relevance seems to be more evident in the non-obese.
KeywordsDZDFamily historyGerman Center for Diabetes ResearchIFGIGTMeta-analysisPrediabetes
Deutsches Zentrum für Diabetesforschung (German Center for Diabetes Research)
Family history of diabetes
Impaired fasting glycaemia
Isolated impaired fasting glycaemia
Impaired glucose tolerance
Isolated impaired glucose tolerance
Cooperative Research in the Region of Augsburg
Metabolic Syndrome Berlin Potsdam
Normal glucose tolerance
Prävention des Diabetes – Selbst aktiv werden (Active in Diabetes Prevention)
Tübingen family study
Prediabetes is a high-risk state for diabetes affecting approximately 470 million people worldwide. However, it is unclear whether all of its subcategories (isolated impaired fasting glucose [iIFG], isolated impaired glucose tolerance [iIGT], and their combination [IFG+IGT]) share the same pathophysiological background with diabetes. The progression rates of prediabetic conditions to diabetes are strikingly different .
A positive family history of type 2 diabetes (FHD) nearly doubles the risk of diabetes in the offspring . As FHD is associated with all characteristic features of diabetes pathophysiology, it may well be that individuals with FHD are at increased risk of prediabetes.
In this study, we performed a meta-analysis from four German studies comprising 8,106 non-diabetic individuals seeking answers for the question whether FHD is associated with prediabetes and whether its subcategories behave differently. We furthermore tested whether these associations are modified by variables such as sex, age and obesity.
Data from four pre-existing cohort studies conducted by partner institutes of the German Center for Diabetes Research (Deutsches Zentrum für Diabetesforschung [DZD]) were used in this meta-analysis. The analysis comprised individuals without previously diagnosed diabetes who underwent 75 g OGTTs in the morning, after at least 10 h fasting. Individuals with incidental diabetes (fasting glucose ≥7.0 or 2 h glucose ≥11.1 mmol/l) were excluded. Prediabetes was taken as including IFG and/or IGT, defined according to the recommendations of the ADA .
Background information on each study population is provided in electronic supplementary material (ESM) Table 1.
The investigations were performed in accordance with the Declaration of Helsinki, and all studies were approved by local ethics committees. All participants provided written informed consent.
Characteristics of the participants of the four study populations
IFG, IGT or IFG+IGT
IFG, IGT or IFG+IGT
IFG, IGT or IFG+IGT
IFG, IGT or IFG+IGT
37 ± 12
45 ± 13
49 ± 14
56 ± 12
50 ± 11
57 ± 10
45 ± 18
55 ± 17
28.3 ± 7.7
34.5 ± 10.8
28.5 ± 6.0
31.3 ± 6.8
26.2 ± 4.3
29.0 ± 4.8
26.0 ± 4.7
27.8 ± 4.8
Family history of diabetes
Yes/No (n/n, % yes)
Fasting plasma/serum glucose (mmol/l)
4.9 ± 0.4
5.7 ± 0.5
4.8 ± 0.4
5.5 ± 0.6
5.0 ± 0.3
5.8 ± 0.5
5.0 ± 0.3
5.8 ± 0.5
Postchallange (2 h) plasma/serum glucose (mmol/l)
5.7 ± 1.1
7.9 ± 1.6
6.1 ± 1.0
8.2 ± 1.4
5.3 ± 1.1
7.2 ± 1.8
5.5 ± 1.2
7.7 ± 1.7
Fasting plasma insulin (pmol/l)
60 ± 50
99 ± 76
57 ± 38
75 ± 48
46 ± 161
82 ± 357
67 ± 50
92 ± 66
Post-challenge (2 h) plasma insulin (pmol/l)
367 ± 352
738 ± 649
304 ± 271
591 ± 428
349 ± 436
601 ± 675
264 ± 203
509 ± 429
Definition of FHD
For this meta-analysis, FHD was uniformly defined as at least one first degree relative with type 2 diabetes. Participants were asked about first degree relatives with type 2 diabetes (parents, siblings or children) using questionnaires or personal interviews. The questionnaire in the Cooperative Research in the Region of Augsburg (KORA) study comprised only parents and siblings.
Data are given as means ± SD. Means were compared with t tests and the Wilcoxon test, as appropriate. Binary outcomes were tested using Fisher’s exact test. Multivariable logistic regression models were used to analyse associations between FHD and prediabetes. Prediabetes categories were applied as dichotomous outcomes (prediabetes vs normal glucose tolerance [NGT], iIFG vs NGT, iIGT vs NGT, IFG+IGT vs NGT). Covariates with non-normal distribution were loge-transformed to approximate normal distribution in the models. ORs and their 95% CIs have been calculated separately in each centre. Age and BMI were dichotomised for interaction tests. For age, a cut-off of 45 years, a numeral close to both the weighted average of the four study populations and the median age in Germany, was used. For BMI, we applied the clinical cut-off for obesity (30 kg/m2).
Calculations were carried out using JMP 8.0 (SAS Institute, Cary, NC, USA) in TUEF (Tübingen Family Study), SAS 9.2 (SAS Institute), in KORA, and IBM SPSS Statistics 18 and 19 (IBM, Ehningen, Germany) in PRAEDIAS (Prävention des Diabetes – Selbst aktiv werden [Active in Diabetes Prevention]) and MeSyBePo (Metabolic Syndrome Berlin Potsdam).
Logistic regression results from all centres were pooled with MIX 2.0 Pro (Version 18.104.22.168, www.biostatxl.com). Fixed-effects models were used throughout the study. Weighting was performed with the Mantel–Haenszel method. Heterogeneity was low (p for Cochrane’s Q >0.05) for all analysed outcome variables, except for iIGT (Q = 12.6, p = 0.006).
We further tested the interaction of FHD with sex, age and obesity in all centres for different prediabetes subcategories (see ESM Table 3). Interaction or a trend for interaction (p < 0.10) with consistent effect direction was observed between FHD and BMI for the determination of prediabetes in two out of four studies. In a subsequent meta-analysis of BMI-stratified subpopulations, the association of FHD with prediabetes was seen only in the non-obese subpopulations, but not in the obese subpopulations (see ESM Figure 1).
In the present analysis of 8,106 individuals characterised by OGTT in four DZD centres, we found that FHD is associated with a 40% increased risk of having prediabetes. When taking additional risk factors such as obesity and age in a multivariable model into account, the strength of the association was attenuated to 26%.
An earlier study from Sweden also found a 50% increased risk of prediabetes in participants with FHD . In our meta-analysis, the OR was lowest for iIGT (1.25) compared with iIFG (1.37) and IFG+IGT (1.64). Given that IGT implies a higher conversion rate to diabetes than IFG , its weaker association with FHD was surprising. As IFG is predominantly associated with hepatic insulin resistance while IGT is often associated with muscle insulin resistance  as well as impaired insulin secretion, one may speculate that FHD might have a stronger link to hepatic insulin resistance. Of note, the lower OR of iIGT is particularly striking in the PRAEDIAS and MeSyBePo studies, and the relatively large inter-centre differences lead to an increased heterogeneity for this variable in the meta-analysis.
An analysis of the Nurses’ Health Study showed that BMI accounted for 21% of the association between FHD and diabetes in women . In the European Prospective Investigation into Cancer and Nutrition (EPIC)–InterAct study, however, lifestyle, anthropometric and genetic risk factors did not sufficiently explain the excess risk associated with FHD . Our data suggest that FHD is associated with prediabetes in non-obese rather than in obese individuals. This might indicate that the effect of FHD on prediabetes becomes readily measurable only when not overshadowed by strong risk factors such as obesity. Most diabetes risk questionnaires, including the German Diabetes Risk Score  and the Finnish Findrisk , heavily rely on markers of obesity. The predictive value of such diabetes risk questionnaires is improved by adding information on family history of diabetes . This improvement could be more striking in the non-obese.
Limitations of our study include its cross-sectional nature and the combination of a population-based study (KORA) with cohort studies specifically recruiting persons with a high risk for type 2 diabetes. In addition, the method of ascertainment of FHD was not identical in each centre.
The association of FHD with increased risk for prediabetes points towards an important role for FHD in the early pathogenesis of diabetes.
We thank all the research volunteers for their participation.
This work was supported by a grant from the German Federal Ministry of Education and Research to the German Center for Diabetes Research.
Duality of interest
The authors declare that there is no duality of interest associated with this manuscript.
RW contributed to data acquisition, analysis, interpretation of data, and drafted and wrote the manuscript. BT contributed to data analysis, interpretation of data, and wrote the manuscript. MAO contributed to data analysis and edited the manuscript. GM, MR, PES and AFP contributed to data acquisition and critically revised the manuscript. AB and HS contributed to data acquisition, interpretation of data, and critically revised the manuscript. CM and BK contributed to data analysis and critically revised the manuscript. WR and FK contributed to data analysis, interpretation of data, and critically revised the manuscript. NS contributed to data acquisition, analysis and critically revised the manuscript. HUH designed the study and critically revised the manuscript. AF designed the study, contributed to data analysis and interpretation of data, and wrote the manuscript. All authors approved the final version of the manuscript to be published.